2 Matching Annotations
  1. Last 7 days
    1. 258 50 c.253_254ins38 p.Leu85fs x x x n/d Offspring -

      PatientID: 258

      KindredID: 258

      Case: Sex Unknown, 50Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Transmission of the variant could not be determined (n/d) since both parents and family history were not available. Child/children were analyzed but no details were provided.

      CasePresentingHPOs: HP:0010797; HP:0001732; HP:0000107 (Hemangioblastoma, Abnormality of the pancreas, Renal cyst)

      CaseHPOFreeText: CNS hemangioblastoma, pancreatic cysts or tumor and renal cystic lesion.

      CaseNotHPOs: HP:0009711; HP:0002666; HP:0006770 (Retinal capillary hemangioma, Pheochromocytoma, Clear cell renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table S1, S2 and S3

      Variant: p.L85fs (c.253_254ins38)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Nucleotides inserted were not specified by the authors.

      MutationType: insertion; frameshift_variant

      CivicName: L85fs (c.253_254ins38)

      MultipleGeneVariants: N/A

    2. In Silico Analysis Protein sequences were retrieved from UniProt (Bairoch et al., 2005) and the VHL protein structure was obtained from the protein data bank (PDB) database (Bourne et al., 2004) (PDB code: 1LM8). A PSI-BLAST (Altschul et al., 1997) search with the pVHL1–213 sequence as query on a nonredundant protein database was performed to collect homologous sequences. The multiple sequence alignment (MSA) was built with CLUSTALW (Thompson et al., 1994), annotated with secondary structure and accessibility values assigned with DSSP (Kabsch & Sander, 1983), and drawn using ESPript (Gouet et al., 1999). The MSA was used as input for Consurf 3.0 (Landau et al., 2005), which calculates the conservation score and visualised in PyMol (De Lano Scientific; URL: http://www.pymol.org/). The Universal Mutation Database (Beroud et al., 1998) (UMD; http://www.umd.be/VHL/) and Human Gene Mutation Database (Stenson et al., 2003) (HGMD; http://www.hgmd.cf.ac.uk/ac/search.html) were used to obtain information about identified variants. Two different splice-site algorithms were used to predict a potential splicing effect: NNSplice (Reese et al., 1997) and NetGene2 (Hebsgaard et al., 1996). Amino acid substitutions were mapped onto the pVHL structure and visually evaluated for their structural effects. Stability changes upon single-site variants were estimated using I-Mutant 3.0 (Capriotti et al., 2008), Eris (Yin et al., 2007), and AutoMute (Masso & Vaisman, 2008). Polyphen (Ramensky et al., 2002), SNPs3D (Yue et al., 2006), PMut (Ferrer-Costa et al., 2005) and SNAP (Bromberg & Rost, 2007) were applied to predict potentially deleterious effects of the new variants. The mutant models for eight new variants were built with ClustAlign (Sommer et al., 2006) and HOMER (http://protein.bio.unipd.it/homer/). GROMACS (Van Der Spoel et al., 2005) was used for 1000 steps of steepest descent minimisation to relax the mutant structures. The RING server (http://protein.bio.unipd.it/ring/) was used to generate the residue interaction network useful for evaluation of structural changes induced by amino acid substitutions. Nodes represent single amino acids of the protein structure, while links represent the noncovalent interactions between them. Default minimum distances were used to define interaction types: 3.0 Å for disulfide bridges; 4.0 Å for salt bridges; 6.0 Å for π–π interaction; and 7.0 Å for π-cation interaction. Connectivity, that is, number of contacts to other residues, and interaction types for each amino acid position found altered, were recorded.